Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

BUY
$14.99 - $32.65 $1.9 Million - $4.15 Million
127,028 New
127,028 $1.9 Million
Q4 2022

Feb 14, 2023

SELL
$40.54 - $56.2 $147,443 - $204,399
-3,637 Reduced 13.58%
23,151 $1.22 Million
Q3 2022

Nov 14, 2022

BUY
$36.98 - $49.2 $990,620 - $1.32 Million
26,788 New
26,788 $1.21 Million
Q4 2021

Feb 14, 2022

SELL
$39.32 - $61.61 $369,018 - $578,209
-9,385 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$44.0 - $65.8 $412,940 - $617,533
9,385 New
9,385 $516,000
Q1 2021

May 17, 2021

SELL
$46.31 - $62.7 $365,663 - $495,079
-7,896 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$55.51 - $69.94 $438,306 - $552,246
7,896 New
7,896 $497,000

Others Institutions Holding SILK

About Silk Road Medical Inc


  • Ticker SILK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 37,565,600
  • Market Cap $1.03B
  • Description
  • Silk Road Medical, Inc. operates as a medical device company in the United States. The company offers various products for the treatment of carotid artery disease called transcarotid artery revascularization. Its products include ENROUTE Transcarotid Neuroprotection System that is used to directly access the common carotid artery and initiate te...
More about SILK
Track This Portfolio

Track Twinbeech Capital LP Portfolio

Follow Twinbeech Capital LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Twinbeech Capital LP, based on Form 13F filings with the SEC.

News

Stay updated on Twinbeech Capital LP with notifications on news.